Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial
Citation:
Ferry, D. and Billingham, L. and Jarrett, H. and Dunlop, D. and Woll, P.J. and Nicolson, M. and Shah, R. and Thompson, J. and Spicer, J. and Muthukumar, D. and Skailes, G. and Leonard, P. and Chetiyawardana, A.D. and Wells, P. and Lewanski, C. and Crosse, B. and Hill, M. and Gaunt, P. and O'Byrne, K., Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial, European Journal of Cancer, 83, 2017, 302-312Download Item:
Author's Homepage:
http://people.tcd.ie/obyrnekeDescription:
PUBLISHEDcited By 1
Author: O'BYRNE, KEN
Type of material:
Journal ArticleCollections
Series/Report no:
European Journal of Cancer83
Availability:
Full text availableDOI:
http://dx.doi.org/10.1016/j.ejca.2017.05.037Metadata
Show full item recordThe following license files are associated with this item: